Live Breaking News & Updates on Radiotracer

Stay updated with breaking news from Radiotracer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

UnivDatos Market Insights Pvt. Ltd.: PET Radiotracer Market is expected to display a steady growth of 8% due to the rise in demand for the effective diagnostic system

NOIDA, India, Feb. 10, 2023 /PRNewswire/ According to a new report published by UnivDatos Markets Insights, the PET Radiotracer Market was valued at more than USD 1.2 million in 2020 ....

United States , United Kingdom , Ankita Gupta , Eli Lilly , Myungmoon Pharm Co Ltd , Data Solutions , Baxter International Inc , Phytex Australia Pty Ltd , Jubilant Pharma , Pfizer Inc , American Cancer Society , Ge Healthcare , Radiopharma Solutions , Customized Business Research , Caleb Pharmaceuticals Inc , Browse Other Related Research , Yantai Dongcheng Pharmaceutical Group Co , Perrigo Company , Cardinal Health , Lantheus Holdings Inc , Fine Chemicals Corporation , Alchem International Pvt , Univdatos Markets Insights , Radiotracer Type , Heart Disease , Neurological Disorders ,

GE Healthcare, Lantheus: Trial Finds Flurpiridaz PET Radiotracer Could Improve CAD Detection

FAIRFIELD (dpa-AFX) - GE Healthcare, the healthcare business of conglomerate General Electric Co. (GE), along with Lantheus Holdings Inc. (LNTH) announced Tuesday that the recent Phase III clinical ....

United States , Francois Tranquart , Lantheus Holdings Inc , More Such Health News , Global Head Of Clinical Development , American Society Of Nuclear Cardiology , Ge Healthcare , General Electric , Lantheus Holdings , Flurpiridaz Positron Emission Tomography , Coronary Artery Disease , Global Head , Clinical Development , Pharmaceutical Diagnostics , Single Photon Emission Computed Tomography , Perfusion Imaging , American Society , Nuclear Cardiology , Label Study ,

GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease

Phase III clinical trial of [18F]flurpiridaz PET diagnostic radiopharmaceutical meets co-primary endpoints for detecting Coronary Artery Disease (CAD) Trial also met its first key secondary ....

United States , New Jersey , Tim Bateman , Debbie Leven , Francois Tranquart , Mark Kinarney , Centers For Disease , Global Head Of Clinical Development , Corporate Communications , Lantheus Holdings Inc , American Society Of Nuclear Cardiology , Ge Healthcare , Coronary Artery Disease , Perfusion Imaging , Molecular Imaging , American Society , Nuclear Cardiology , Positron Emission Tomography , Single Photon Emission Computed Tomography , Myocardial Perfusion Imaging , Open Label Study , Cardiovascular Radiologic Imaging Program , Saint Luke , Global Head , Clinical Development , Pharmaceutical Diagnostics ,

New PET tracer effective for diagnosing neuroendocrine tumors

A new gallium-68 PET radiotracer appears effective for predicting higher risk of disease progression and death in patients with neuroendocrine tumors. ....

Esben Carlsen , Siemens Healthineers , University Of Copenhagen , Journal Of Nuclear Medicine , Copenhagen University Hospital , Medical Imaging , Neuroendocrine Tumors , A 68 Nodaga Ec Rgdyk 2 , Ntegrin Alphav Beta 3 ,

PET-based model may help stage Alzheimer's disease patients

Researchers have developed a new model for diagnosing the severity of Alzheimer's disease based largely on the spatial topography of brain PET imaging. ....

Joseph Therriault , Pedro Rosa Neto , Mcgill University , Clinical Dementia Rating , Medical Imaging , Ocioeconomic Updates , Lzheimer 39s Disease , Tau Pet , Neurofibrillary Tangles , F 18 Mk 6240 , Raak Staging ,